The Effects of STW 5-II on Duodenal Mucosa and Symptoms in Functional Dyspepsia

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2028

Conditions
Functional Dyspepsia
Interventions
DRUG

STW 5-II

"STW 5-II is an herbal medicinal product for the symptomatic treatment of functional dyspepsia with main symptoms such as epigastric pain, epigastric burning, postprandial fullness and early satiation, but often also loss of appetite, excessive belching and heartburn. STW5-II consists of six herbal extracts: bitter candy tuft, camomile flower, caraway fruit, melissa leaf, peppermint leaf, and licorice root.~STW 5-II will be a solution for oral intake, for the treatment of FD, administered as 20 droplets in liquids, three times daily during 8 weeks. Recommended time of ingestion is just before or with meals. Patients and study staff are blinded for the intervention"

DRUG

Placebo

Matching placebo will be a solution for oral intake, administered as 20 droplets in liquids, three times daily during 8 weeks. Recommended time of ingestion is just before or with meals. Patients and study staff are blinded for the intervention.

Trial Locations (1)

3000

University Hospitals Leuven / UZLeuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT07198243 - The Effects of STW 5-II on Duodenal Mucosa and Symptoms in Functional Dyspepsia | Biotech Hunter | Biotech Hunter